Surgery for infective endocarditis

Current Infectious Disease Reports

Volumn 9, Issue 4, 2007, Pages 291-296

  Brown, Patricia D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ECHINOCANDIN; FLUCYTOSINE; PENICILLIN G; PYRROLE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; CAUSE OF DEATH; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; EMBOLISM; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PROGNOSIS; PROSTHESIS INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; STROKE; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 34547442445     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-007-0045-9     Document Type: Review

References (46)

1. Rankin JS, Hammill BG, Ferguson TB Jr, et al.: Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 2006, 131:547-557.
2. Tleyjeh IM, Steckelberg JM, Murad HS, et al.: Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022-3028.
3. Fowler VG Jr, Miro JM, Hoen B, et al.: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
4. Durack DT: Evaluating and optimizing outcomes of surgery for endocarditis. JAMA 2003, 290:3250-3251.
5. Sexton DJ, Spelman D: Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Cardiol Clin 2003, 21:273-282 vii-viii.
6. Baddour LM, Wilson WR, Bayer AS, et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394-434.
7. Olaison L, Pettersson G: Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 2002, 16:453-475, xi.
8. Chastre J, Trouillet JL: Early infective endocarditis on prosthetic valves. Eur Heart J 1995, 16(Suppl B):32-38.
9. d'Udekem Y, David TE, Feindel CM, et al.: Long-term results of surgery for active infective endocarditis. Eur J Cardiothorac Surg 1997, 11:46-52.
10. Moon MR, Stinson EB, Miller DC: Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997, 40:239-264.
11. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ: Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003, 290:3207-3214.
12. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997, 127(8 Pt 2):757-763.
13. Cabell CH, Abrutyn E, Fowler VG Jr, et al.: Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 2005, 150:1092-1098.
14. Aksoy O, Sexton DJ, Wang A, et al.: Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 2007, 44:364-372.
15. Steinbach WJ, Perfect JR, Cabell CH, et al.: A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect 2005, 51:230-247.
16. Lye DC, Hughes A, O'Brien D, Athan E: Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis 2005, 24:753-735.
17. Aubron C, Charpentier J, Trouillet JL, et al.: Native-valve infective endocarditis caused by Enterobacteriaceae: report on 9 cases and literature review. Scand J Infect Dis 2006, 38:873-881.
18. Chirouze C, Cabell CH, Fowler VG Jr, et al.: Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis 2004, 38:1323-1327.
19. Wang A, Pappas P, Anstrom KJ, et al.: The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J 2005, 150:1086-1091.
20. Sohail MR, Martin KR, Wilson WR, et al.: Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med 2006, 119:147-154.
21. Steckelberg JM, Murphy JG, Ballard D, et al.: Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991, 114:635-640.
22. Eishi K, Kawazoe K, Kuriyama Y, et al.: Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995, 110:1745-1755.
23. Ruttmann E, Willeit J, Ulmer H, et al.: Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006, 37:2094-2099.
24. Di Salvo G, Habib G, Pergola V, et al.: Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001, 37:1069-1076.
25. Mugge A, Daniel WG, Frank G, Lichtlen PR: Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989, 14:631-638.
26. De Castro S, Magni G, Beni S, et al.: Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997, 80:1030-1034.
27. Vilacosta I, Graupner C, San Roman JA, et al.: Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002, 39:1489-1495.
28. Deprele C, Berthelot P, Lemetayer F, et al.: Risk factors for systemic emboli in infective endocarditis. Clin Microbiol Infect 2004, 10:46-53.
29. Sexton DJ, Spelman D: Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Infect Dis Clin North Am 2002, 16:507-521, xii.
30. Bashore TM, Cabell C, Fowler V Jr: Update on infective endocarditis. Curr Probl Cardiol 2006, 31:274-352.
31. Kay PH, Oldershaw PJ, Dawkins K, et al.: The results of surgery for active endocarditis of the native aortic valve. J Cardiovasc Surg (Torino) 1984, 25:321-327.
32. Fowler VG, Scheld MW, Bayer AS: Endocarditis and intravascular infections. In Principles and Practice of Infectious Diseases, 6th edn. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Elsevier Churchill Livingstone; 2005:975-1022.
33. Habib G, Tribouilloy C, Thuny F, et al.: Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart 2005, 91:954-959.
34. Levine DP, Fromm BS, Reddy BR: Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991, 115:674-680.
35. Graves MK, Soto L: Left-sided endocarditis in parenteral drug abusers: recent experience at a large community hospital. South Med J 1992, 85:378-380.
36. Mathew J, Addai T, Anand A, et al.: Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995, 155:1641-1648.
37. Kaiser SP, Melby SJ, Zierer A, et al.: Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg 2007, 83:30-35.
38. Miro JM, del Rio A, Mestres CA: Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am 2002, 16:273-295, vii-viii.
39. Manoff SB, Vlahov D, Herskowitz A, et al.: Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology 1996, 7:566-570.
40. Mestres CA, Chuquiure JE, Claramonte X, et al.: Longterm results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). Eur J Cardiothorac Surg 2003, 23:1007-1016; discussion 1016.
41. Feringa HH, Bax JJ, Klein P, et al.: Outcome after mitral valve repair for acute and healed infective endocarditis. Eur J Cardiothorac Surg 2006, 29:367-373.
42. Gammie JS, O'Brien SM, Griffith BP, Peterson ED: Surgical treatment of mitral valve endocarditis in North America. Ann Thorac Surg 2005, 80:2199-2204.
43. Zegdi R, Debieche M, Latremouille C, et al.: Long-term results of mitral valve repair in active endocarditis. Circulation 2005, 111:2532-2536.
44. Arbulu A, Thoms NW, Chiscano A, Wilson RF: Total tricuspid valvulectomy without replacement in the treatment of Pseudomonas endocarditis. Surg Forum 1971, 22:162-164.
45. Arbulu A: Trivalvular/bivalvular heart: a philosophical, scientific and therapeutic concept. J Heart Valve Dis 2000, 9:353-357; discussion 357-358.
46. Morris AJ, Drinkovic D, Pottumarthy S, et al.: Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis 2003, 36:697-704.